NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer with Exploratory Biomarker Correlatives

Robert L. Ferris, Julie E. Bauman, Ravindra Uppaluri et al.|International Journal of Radiation Oncology*Biology*Physics|2024

Cited by 0